DWA
GILD icon

Dorsey Wright & Associates’s Gilead Sciences GILD Stock Holding History

Dorsey Wright & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,474
Closed -$1.32M – 151
2026
Q1 		$1.32M Buy
+9,474
New +$1.33M 0.16% 113
2023
Q3 		– Sell
-28,091
Closed -$2.17M – 297
2023
Q2 		$2.17M Sell
28,091
-579
-2% -$46.2K 0.65% 82
2023
Q1 		$2.38M Buy
+28,670
New +$2.37M 0.72% 85
2015
Q3 		– Sell
-16,053
Closed -$1.84M – 112
2015
Q2 		$1.84M Buy
16,053
+104
+0.7% +$11.4K 0.89% 32
2015
Q1 		$1.56M Sell
15,949
-11,037
-41% -$1.12M 0.72% 40
2014
Q4 		$2.54M Buy
26,986
+10,445
+63% +$1.08M 1.17% 20
2014
Q3 		$1.76M Sell
16,541
-248
-1% -$24.3K 0.25% 43
2014
Q2 		$1.51M Buy
16,789
+63
+0.4% +$4.9K 0.18% 55
2014
Q1 		$1.24M Sell
16,726
-19,799
-54% -$1.55M 0.17% 58
2013
Q4 		$2.88M Buy
36,525
+19,642
+116% +$1.37M 0.42% 36
2013
Q3 		$1.06K Buy
16,883
+180
+1% +$10.8K 0.15% 55
2013
Q2 		$856K Buy
+16,703
New +$871K 0.14% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dorsey Wright & Associates's GILD Position: Q2 2026 in Review

Dorsey Wright & Associates sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 9,474 shares — an estimated $1.32M sold.

Dorsey Wright & Associates first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $2.88M in Q4 2013. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dorsey Wright & Associates reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Dorsey Wright & Associates sold 9,474 Gilead Sciences shares in Q2 2026, an estimated $1.32M.
  • Dorsey Wright & Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Dorsey Wright & Associates's Gilead Sciences position peaked at $2.88M in Q4 2013.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.